A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a complex, heterogeneous, and genetically unstable disease. Its tumor microenvironment (TME) is complicated by heterogeneous cancer cell populations and strong desmoplastic stroma. This complex and heterogeneous environment makes it challenging to discover and validate unique therapeutic targets. Reliable and relevant in vitro PDAC tumor models can significantly advance the understanding of the PDAC TME and may enable the discovery and validation of novel drug targets. In this study, an engineered tumor model is developed to mimic the PDAC TME. This biomimetic model, named ductal tumor-microenvironment-on-chip (dT-MOC), permits analysis and experimentation on the epithelial-mesenchymal transition (EMT) and local invasion with intratumoral heterogeneity. This dT-MOC is a microfluidic platform where a duct of murine genetically engineered pancreatic cancer cells is embedded within a collagen matrix. The cancer cells used carry two of the three mutations of KRAS, CDKN2A, and TP53, which are key driver mutations of human PDAC. The intratumoral heterogeneity is mimicked by co-culturing these cancer cells. Using the dT-MOC model, heterogeneous invasion characteristics, and response to transforming growth factor-beta1 are studied. A mechanism of EMT and local invasion caused by the interaction between heterogeneous cancer cell populations is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To address these challenges, a chip-based biomimetic ductal TME was developed to replicate the microanatomy of PDAC (Bradney et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“This model facilitated the exploration of varied local invasion patterns in response to TGF-β1 based on genotype and phenotype, as well as the investigation of heterogeneous interactions among diverse cancer cell populations (Bradney et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“Murine pancreatic cancer cells from two genetically engineered mouse models, representing common PDAC mutations, were utilized—one with KRAS and TP53 mutations and the other with KRAS and CDKN2A mutations, displaying distinct mesenchymal and epithelial phenotypes.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“The model consisted of a duct lined with pancreatic cancer cell epithelium embedded in a collagen matrix, forming a perfusable epithelial lumen that mimicked physiological biomechanical forces.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Bradney et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Cited by
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
Haque, M. R., Wessel, C. R., Leary, D. D., Wang, C., Bhushan, A., & Bishehsari, F. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00370-6 · Cited by 137
Wang, G., Zhang, C., Jiang, Y., Song, Y. H., Chen, J., Sun, Y., Li, Q., Zhou, Z., Shen, Y., & Huang, P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102786 · Cited by 99
Microfluidics meets 3D cancer cell migration
Mehta, P., Rahman, Z., ten Dijke, P., & Boukany, P. E. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.006 · Cited by 85
The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Cave, D. D., Rizzo, R., Sáinz, B., Gigli, G., del Mercato, L. L., & Lonardo, E. (2021) · Cancers · doi:10.3390/cancers13040930 · Cited by 50
Metadata
- Authors
- Bradney, M. J., Venis, S. M., Yang, Y., Konieczny, S. F., & Han, B.
- Affiliations
- Purdue University West Lafayette (US)
- Corresponding author
- Han, Bumsoo
- Venue
- Small
- Publisher
- Wiley
- Published
- 2020-01-30
- Volume
- 16
- Issue
- 10
- Pages
- e1905500-e1905500
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- PMC
- PMC7069790
- OpenAlex
- W3003341929
- Cited by
- 38
- References
- 63
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 3
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Small (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (U01 HL143403, UL1 TR002529, R01 CA211098, R01 CA124586)
- Purdue University Center for Cancer Research (P30 CA023168)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- pancreatic ductal adenocarcinoma, tumor microenvironment, organ-on-a-chip, epithelial-mesenchymal transition, local invasion, intratumoral heterogeneity, desmoplastic stroma, KRAS, CDKN2A, TP53, TGF-β1, collagen matrix
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasm Invasiveness, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Biomimetics, Microfluidics, Cell Line, Tumor, Mice, Epithelial-Mesenchymal Transition, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.